top of page

Q4 results of Smith&Nephew, NuVASIVE

  • Spine bussiness is meeting solid milestones


  • Smith & Nephew, new leadership resulted in 7 % rise in stock


  • NuVasive expected to grow 4 - 6 % in 2020


Read more


source: Medtechdive





25 views0 comments

Recent Posts

See All

Dear all, here are the great sources that caught our eye in the last weeks regarding the medical device industry outlook as of 2021. Including: - EY report, 2021 - McKinsey report, 2021 - MedTech Dive

bottom of page